AD
(3beta,23R)-23-Hydroxy-14,15,16,17-tetradehydroveratraman-3-yl beta-D-glucopyranoside(CAS: 475-00-3)
CAS Number
Related Products
![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://static.chemtradehub.com/structs/667/66791-77-3-74b7.webp)
![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://static.chemtradehub.com/structs/346/34620-78-5-d616.webp)
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS Number: 34620-78-5
![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://static.chemtradehub.com/structs/699/69915-09-9-afab.webp)
Ganoderic acid LM2
CAS Number: 508182-41-0
Other Suppliers for (3beta,23R)-23-Hydroxy-14,15,16,17-tetradehydroveratraman-3-yl beta-D-glucopyranoside
Basic Information
Molecular Formula
C33H49NO7
Molecular Weight
571.76 g/mol
Physical State
Powder
Physical Properties
Melting Point
237.8-239.7 ºC (methanol )
Chemical Identifiers
SMILES
CC1CC(C(NC1)C(C)C2=C(C3=C(C=C2)C4CC=C5CC(CCC5(C4C3)C)OC6C(C(C(C(O6)CO)O)O)O)C)O
InChIKey
WXQHVBNTINGJJR-NIFRNHPISA-N
Database References
MDL Number
MFCD01675321
Beilstein Registry Number
0071979
FAQ
The compound is a crystalline solid with a molecular weight of approximately 446.42 g/mol. It has limited water solubility and is soluble in organic solvents like ethanol and methanol. Chemically, it is reactive with bases and exhibits low reactivity with acids. Its crystalline form provides stability under normal conditions.
The compound is typically synthesized via glycosylation of 23-hydroxy-14,15,16,17-tetradehydroveratraman-3-one, using a suitable glycosylating agent and a base as the catalyst. The synthesis involves careful control of reaction conditions to achieve high selectivity and yield.
This compound finds applications in the pharmaceutical industry as a potential drug candidate. It may also be used in the development of biosensors and in research related to natural product chemistry and plant biology.
Proper personal protective equipment (PPE) such as gloves, goggles, and a lab coat should be worn. Handle in a well-ventilated area or fume hood to avoid inhalation. Store at room temperature away from light and moisture. In case of accidental spill, neutralize with an appropriate acid-base buffer and dispose of according to local regulations. Refer to the Safety Data Sheet (SDS) for detailed handling instructions.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures